GENinCode Plc (LON:GENI – Get Free Report)’s stock price dropped 6.5% during mid-day trading on Friday . The company traded as low as GBX 7.05 ($0.09) and last traded at GBX 7.25 ($0.09). Approximately 202,278 shares were traded during trading, a decline of 33% from the average daily volume of 304,165 shares. The stock had previously closed at GBX 7.75 ($0.10).
GENinCode Stock Performance
The company has a quick ratio of 15.89, a current ratio of 5.92 and a debt-to-equity ratio of 6.74. The firm has a market capitalization of £12.83 million, a P/E ratio of -120.83 and a beta of 0.40. The stock has a fifty day moving average of GBX 5.79 and a 200-day moving average of GBX 5.99.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Featured Articles
- Five stocks we like better than GENinCode
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Stocks Leading the U.S. Agriculture Comeback
- Why Invest in 5G? How to Invest in 5G Stocks
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
